E2 ModerateWeak / uncertainPEM unclearCross-SectionalPeer-reviewedMachine draft
Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
Arredondo, Miguel, Hackett, John, de Bethencourt, Fermín R et al. · AIDS research and human retroviruses · 2012 · DOI
Quick Summary
Researchers tested blood samples from over 1,100 people in Spain, including those with ME/CFS and fibromyalgia, to look for a virus called XMRV that had been suggested as a possible cause of these conditions. They found no reliable evidence that XMRV was present in any of the groups they studied, including people with ME/CFS, cancer, other viral infections, or healthy blood donors.
Why It Matters
This study is important because early reports suggested XMRV might be linked to ME/CFS, raising hope for a viral explanation. A large, well-designed study finding no XMRV in ME/CFS patients helps clarify that this particular virus is unlikely to be a major cause, refocusing research efforts on other potential mechanisms.
Observed Findings
- Three samples (0.3%) were p15E seroreactive; all were from HTLV-1 or HCV patients, not ME/CFS patients.
- Fifteen samples (1.4%) were gp70 seroreactive, including six from ME/CFS/fibromyalgia patients, four from blood donors, and one or two each from other groups.
- Four specimens initially tested positive for XMRV gag sequences but could not be confirmed by repeat testing.
- No confirmed XMRV DNA sequences were detected in any study group after validation.
Inferred Conclusions
- XMRV infection was not detected in ME/CFS or fibromyalgia patients in this Spanish cohort.
- XMRV was not found in populations with other retroviral infections, viral hepatitis, autoimmune diseases, prostate cancer, or healthy blood donors.
- The initial positive results for gag sequences likely represented false positives or contamination, as confirmatory testing failed.
Remaining Questions
- Why were low levels of gp70 seropositivity observed in multiple groups if not from XMRV infection—could these represent cross-reactivity or non-specific responses?
- Would higher-sensitivity molecular methods detect XMRV in other geographic regions or specific ME/CFS subpopulations?
- What other viral or infectious agents should be investigated as potential contributors to ME/CFS pathogenesis?
What This Study Does Not Prove
This study does not prove that no virus is involved in ME/CFS—only that XMRV specifically was not detected in this Spanish population. The negative findings in a single country do not exclude XMRV's presence in other geographic populations, nor do they rule out other infectious agents. Cross-sectional serological testing has inherent limitations in sensitivity and specificity.
Tags
Symptom:Fatigue
Biomarker:AutoantibodiesBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleMixed Cohort
Metadata
- DOI
- 10.1089/AID.2011.0149
- PMID
- 22206583
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →